EUVIMEDEUVIMED entdecken
Crossref

Glioblastoma–Neuroblastoma Cocultured Multicellular Spheroid Model for Evaluating Temozolomide Response

Sivasubramanian Murugappan iD, Ajay Mali iD, Puja Sandbhor iD, Nanasaheb Thorat iD

ChemBioChem · 26.11.2026 · 27 (22)

DOI: 10.1002/cbic.70606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 18.11.2026. Verfasst von Sivasubramanian Murugappan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Bernal Institute, University of Limerick, Limerick, Ireland. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Research Ireland (formerly Science Foundation Ireland), Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most lethal primary brain tumor, and its resistance to therapy is increasingly understood to arise not from tumor cells alone but also from their integration into the surrounding neural circuitry. However, no existing preclinical spheroid model isolates the direct effect of neuronal‐lineage cells on glioblastoma's drug response within a rapid, scalable 3D system. We developed a heterotypic 3D coculture spheroid combining glioblastoma (U87‐MG) with a neuronal‐lineage surrogate population (SH‐SY5Y) via the agarose liquid overlay method to directly understand this gap. Subsequently, growth, morphology, hypoxia, and temozolomide (TMZ) response over 14 days against glioblastoma only and neuroblastoma only spheroids were characterized. The coculture adopted a glioblastoma like compact, chemoresistant architecture yet, contrary to what this architecture alone would predict, it showed measurable chemosensitivity at every TMZ concentration tested, including 10 µM, a dose at which neither monoculture responded at all. This indicates that the neuronal‐lineage surrogate population alters the overall TMZ response of the coculture spheroids. Drug‐response data from glioblastoma only models may therefore not reflect true tumor behavior in the presence of neuronal‐lineage cells, supporting the inclusion of neuronal‐lineage surrogate components in preclinical glioblastoma drug screening.

Schlagwörter

Stichwörter der Autor:innen

SH‐SY5YU87‐MGcoculturedrug screeningglioblastomaneuroblastomaspheroidtemozolomide

Autor:innen und Institutionen

  • Department of Physics and Bernal Institute, University of Limerick, Limerick, Ireland.
  • Translational Nanomedicine and Bioengineering Lab, Department of Radiation Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research, and Education in Cancer, Navi-Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Limerick Digital Cancer Research Centre (LDCRC), University of Limerick, Limerick, Ireland.

ORCID-Profile: Sivasubramanian Murugappan, Ajay Mali, Puja Sandbhor, Nanasaheb Thorat

Förderung

  • Research Ireland (formerly Science Foundation Ireland)
  • Irish Research Council

Zitieren

APA

Murugappan, S., Mali, A., Sandbhor, P., & Thorat, N. (2026). Glioblastoma–Neuroblastoma Cocultured Multicellular Spheroid Model for Evaluating Temozolomide Response. ChemBioChem, 27(22). https://doi.org/10.1002/cbic.70606

Vancouver

Murugappan S, Mali A, Sandbhor P, Thorat N. Glioblastoma–Neuroblastoma Cocultured Multicellular Spheroid Model for Evaluating Temozolomide Response. ChemBioChem. 2026;27(22). doi:10.1002/cbic.70606

BibTeX
@article{Murugappan2026,
  author = {Murugappan, Sivasubramanian and Mali, Ajay and Sandbhor, Puja and Thorat, Nanasaheb},
  title = {Glioblastoma–Neuroblastoma Cocultured Multicellular Spheroid Model for Evaluating Temozolomide Response},
  journal = {ChemBioChem},
  year = {2026},
  volume = {27},
  number = {22},
  doi = {10.1002/cbic.70606}
}
Kostenlos starten →